Search Within

Ellen M Hollywood

Formats
  1. Meeting Abstract (23)
  2. Journal Article (17)
  3. Book Section (1)
Groups
  1. Advanced Practice Providers (41)
  2. Nursing (41)
  3. Department of Medicine (37)
  4. Gastrointestinal Oncology Service (37)
  5. Solid Tumor Oncology Division (37)
  6. Center for Pancreatic Cancer Research (28)

More Groups

People
  1. Leonard Saltz (27)
  2. Eileen O'Reilly (15)
  3. Marinela Capanu (14)
  4. Ghassan Abou-Alfa (11)
  5. David Kelsen (9)
  6. James Harding (9)

More People

Years
  1. 2019 (1)
  2. 2018 (4)
  3. 2017 (4)
  4. 2015 (3)
  5. 2014 (3)
  6. 2013 (2)

More Years

Publications
  1. Journal of Clinical Oncology (22)
  2. Clinical Cancer Research (3)
  3. Annals of Oncology (2)
  4. Cancer (2)
  5. European Journal of Cancer (2)
  6. Oncology Nursing Forum (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (22)
  2. American Association for Cancer Research (3)
  3. Elsevier Inc. (3)
  4. Oxford University Press (3)
  5. Oncology Nursing Society (ONS) (2)
  6. Springer (2)

More Publishers

Results (41)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • First stage results of a phase II trial of sorafenib plus doxorubicin (SD) in patients (pts) with advanced hepatocellular carcinoma (HCC) who progressed (POD) on sorafenib (S)
    Meeting Abstract

    Abou-Alfa, G. K.; Capanu, M.; Do, R. K. G.; Hollywood, E.; Ly, M.; Chou, J. F.; Lee, J. K.; Connell, L. C.; Wan, P. J.; Bradley, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase II trial of veliparib (V) in patients (pts) with previously treated BRCA or PALB2-mutated (mut) pancreas adenocarcinoma (PC)
    Meeting Abstract

    Lowery, M. A.; Kelsen, D. P.; Smith, S. C.; Moore, M.; Kindler, H. L.; Golan, T.; Segal, A.; Hollywood, E.; Maynard, H.; Capanu, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase IB trial of cisplatin (C), gemcitabine (G), and veliparib (V) in patients with known or potential BRCA or PALB2-mutated pancreas adenocarcinoma (PC)
    Meeting Abstract

    O'Reilly, E. M.; Lowery, M. A.; Segal, M. F.; Smith, S. C.; Moore, M. J.; Kindler, H. L.; Golan, T.; Segal, A.; Salo-Mullen, E. E.; Hollywood, E.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Phase 1b study of R05137382/GC33 in combination with sorafenib in patients with advanced hepatocellular carcinoma (HCC) (NCT00976170)
    Meeting Abstract

    Abou-Alfa, G. K.; Yen, C. J.; Carrasquillo, J. A.; Hsu, C. H.; Gansukh, B.; Ma, J.; Hollywood, E.; Wan, P. J.; Shao, Y. Y.; Lin, Z. Z.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Neoadjuvant chemotherapy without routine use of radiation therapy for patients with locally advanced rectal cancer: A pilot trial
    Journal Article

    Schrag, D.; Weiser, M. R.; Goodman, K. A.; Gonen, M.; Hollywood, E.; Cercek, A.; Reidy-Lagunes, D. L.; Gollub, M. J.; Shia, J.; Guillem, J. G.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Randomized phase II study of gemcitabine (G), cisplatin (C) with or without veliparib (V) (arms A, B) and a phase II single-arm study of single-agent veliparib (arm C) in patients with BRCA or PALB2-mutated pancreas adenocarcinoma (PC)
    Meeting Abstract

    O'Reilly, E. M.; Lowery, M. A.; Yu, K. H.; Capanu, M.; Stadler, Z. K.; Epstein, A. S.; Golan, T.; Segal, A.; Segal, M.; Salo-Mullen, E. E.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase I study of LOR-253, a novel inducer of Kruppel-like factor 4, in patients with advanced solid tumors
    Meeting Abstract

    Cercek, A.; Wheler, J.; Weisberger, E.; Anderson, R.; Hollywood, E.; Zhou, S.; Murray, P.; Lee, Y.; Zinner, R.; Saltz, L.
    European Journal of Cancer (2013)

    Fulltext@MSK | Save
  • Phase II study of ganetespib, an hsp-90 inhibitor, in patients with refractory metastatic colorectal cancer
    Meeting Abstract

    Cercek, A.; Shia, J. R.; Gollub, M.; Raasch, P. J.; Hollywood, E.; Reidy, D. L.; Janjigian, Y. Y.; Stadler, Z. K.; Segal, N. H.; O'Reilly, E. M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A phase 2 study of the insulin-like growth factor-1 receptor inhibitor MK-0646 in patients with metastatic, well-differentiated neuroendocrine tumors
    Journal Article

    Reidy-Lagunes, D. L. ; Vakiani, E.; Segal, M. F.; Hollywood, E. M.; Tang, L. H.; Solit, D. B.; Pietanza, M. C.; Capanu, M.; Saltz, L. B.
    Cancer (2012)

    Fulltext@MSK | Save
  • Phase I study of two schedules of oral S-1 in combination with fixed doses of oxaliplatin and bevacizumab in patients with advanced solid tumors
    Journal Article

    Chung, K. Y.; Saito, K.; Zergebel, C.; Hollywood, E.; Segal, M.; Saltz, L. B.
    Oncology (2011)

    Fulltext@MSK | Save